Burns

• EMA approval · 2025-12-03
  EMA Authorised: NexoBrid (proteolytic enzymes enriched in bromelain) — MediWound Germany GmbH

  EMA has authorised NexoBrid, a bromelain-based proteolytic enzyme product, for debridement in burn wounds. The approval is granted to MediWo…

• FDA approval · 2024-08-15
  FDA Approved: NEXOBRID — Supplemental Application (Vericel Corporation)

  The FDA approved a supplemental application for NEXOBRID (ANACAULASE-BCDB) from Vericel Corporation, indicating an update to the product's a…

• FDA approval · 2016-08-01
  FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Silver Sulfadiazine submitted by Mylan Pharmaceuticals.

• FDA approval · 2014-04-21
  FDA Approved: SSD CREAM — Supplemental Application (Dr Reddys Laboratories Inc)

  FDA approved a supplemental application for SSD CREAM (silver sulfadiazine) from Dr. Reddy's Laboratories Inc. The approval relates to a sup…

• FDA approval · 2013-03-06
  FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Silver Sulfadiazine submitted by Mylan Pharmaceuticals.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2012-11-27
  FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Ascend Laboratories, LLC)

  The FDA approved a supplemental application for Silver Sulfadiazine by Ascend Laboratories, LLC.

• FDA approval · 2012-11-13
  FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for SILVER SULFADIAZINE from Mylan Pharmaceuticals Inc., marking a regulatory action related to the …